Overview
Ectodermal dysplasia-absent dermatoglyphs syndrome, also known as Basan syndrome or ectodermal dysplasia with absent dermatoglyphics, is an extremely rare genetic condition characterized by the congenital absence of dermatoglyphics (fingerprints and other skin ridge patterns on the hands and feet) combined with features of ectodermal dysplasia. This condition primarily affects the skin and its appendages. Key clinical features include absent or reduced fingerprints (adermatoglyphia), facial milia (small white cysts on the skin, particularly the face) that may appear in infancy and resolve over time, and blistering of the skin, especially on the hands and feet. Some affected individuals may also have nail abnormalities and reduced sweating. The condition is present from birth, with blistering often noted in the neonatal period. This entry is marked as OBSOLETE in Orphanet, suggesting it may have been reclassified or merged with another condition. The phenotype overlaps with what has been described as adermatoglyphia or 'immigration delay disease,' and some cases may now be classified under SMARCAD1-related conditions. The syndrome was first described by Basan in 1965 in a large family. There is no specific treatment for this condition; management is supportive and focuses on skin care, prevention of blistering, and monitoring of ectodermal features. Genetic counseling is recommended for affected families.
Also known as:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.
Start the conversation →Latest news about OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome
No recent news articles for OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome
What is OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome?
Ectodermal dysplasia-absent dermatoglyphs syndrome, also known as Basan syndrome or ectodermal dysplasia with absent dermatoglyphics, is an extremely rare genetic condition characterized by the congenital absence of dermatoglyphics (fingerprints and other skin ridge patterns on the hands and feet) combined with features of ectodermal dysplasia. This condition primarily affects the skin and its appendages. Key clinical features include absent or reduced fingerprints (adermatoglyphia), facial milia (small white cysts on the skin, particularly the face) that may appear in infancy and resolve over
How is OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome inherited?
OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome typically begin?
Typical onset of OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome is neonatal. Age of onset can vary across affected individuals.